This session will explore the potential for bacteriophage therapy as an anti-bacterial therapy for airway infection in CF. The session will include three presentations that will focus on (i) the fundamentals of bacteriophage biology, (ii) a brief history of the use of bacteriophages as anti-infective therapy in humans, and (iii) potential obstacles to the use of bacteriophage therapy in CF.
Review the basics of bacteriophage biology and ecology with respect to their antibacterial activity.
Describe the history of bacteriophages as antibacterial therapy for human infection.
Summarize the potential obstacles that challenge the use of bacteriophages for therapy of airway infection in CF.